NIH-funded research R01 grant

Oxytocin sensitivity and postpartum bleeding risk markers

Official title: Oxytocin sensitivity and postpartum hemorrhage: testing genetic and epigenetic biomarkers for improving maternal morbidity

Funded at University of Arizona · NIH-11362224 · Data updated 2026-11-12

This project looks at genetic and epigenetic clues to predict and prevent heavy bleeding after childbirth.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Arizona
NIH-funded
Lab location1 site (Tucson, United States)
Project startAugust 1, 2023
Project endMay 31, 2028
Funding year2026
Award (this year)$715,188
NIH project number5R01HD111125-04
Project IDNIH-11362224 on NIH RePORTER

Who could benefit from this research

Could help

People who are pregnant and at risk for postpartum hemorrhage, especially those with labors induced or with a personal/family history of hemorrhage and people of color.

Less likely to help

Participants without the identified risk factors or without a role in the biomarker analyses may not directly benefit.

What this research studies

Postpartum hemorrhage affects a significant number of births in the U.S. and is linked to higher risk for people of color and during induced labor. The study will explore how genetic and epigenetic factors influence how the uterus responds to oxytocin, a drug used to start or augment labor and to control bleeding after delivery. Researchers will examine biological markers and biosocial factors to improve prediction of who might experience heavy bleeding and who may need additional treatments. The goal is to identify new risk indicators that could guide personalized care and reduce maternal morbidity.

Why it matters

Potential benefit: If successful, the work could lead to better identification of at-risk patients and more targeted interventions to prevent severe postpartum hemorrhage.

How similar studies have gone: Prior work shows oxytocin response varies among individuals and that biomarkers can relate to uterine contractility, but precise predictive biomarkers are still being explored.

Where this research is happening

  • University of Arizona
    Tucson, United States
    Active

Researchers

  • Principal investigator: Erickson, Elise N — University of Arizona
  • Study coordinator: Erickson, Elise N

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.